AAMU
GSK icon

Amundi Asset Management US’s GSK GSK Stock Holding History

Amundi Asset Management US’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-273,614
Closed -$13.1K – 1653
2018
Q4 		$13.1K Sell
273,614
-195,576
-42% -$9.63M 0.01% 578
2018
Q3 		$23.6M Buy
469,190
+106,484
+29% +$5.41M 0.03% 497
2018
Q2 		$18.3M Sell
362,706
-25,919
-7% -$1.31M 0.03% 549
2018
Q1 		$19M Sell
388,625
-2,032
-0.5% -$94.6K 0.03% 499
2017
Q4 		$17.3M Sell
390,657
-104,683
-21% -$4.84M 0.03% 511
2017
Q3 		$25.1M Sell
495,340
-3,858
-0.8% -$196K 0.08% 193
2017
Q2 		$26.9M Buy
499,198
+65,978
+15% +$3.52M 0.09% 177
2017
Q1 		$22.8M Sell
433,220
-3,280
-0.8% -$166K 0.08% 192
2016
Q4 		$21M Buy
436,500
+2,880
+0.7% +$142K 0.07% 208
2016
Q3 		$23.4M Sell
433,620
-880
-0.2% -$48.3K 0.08% 202
2016
Q2 		$23.5M Sell
434,500
-6,716
-2% -$354K 0.09% 187
2016
Q1 		$22.4M Hold
441,216
– – 0.08% 192
2015
Q4 		$22.3M Sell
441,216
-24,481
-5% -$1.25M 0.08% 205
2015
Q3 		$22.4M Sell
465,697
-595,633
-56% -$31M 0.09% 207
2015
Q2 		$55.3M Buy
1,061,330
+94,194
+10% +$5.3M 0.2% 133
2015
Q1 		$55.8M Buy
967,136
+2,175
+0.2% +$125K 0.2% 128
2014
Q4 		$51.6M Buy
964,961
+699,555
+264% +$39.1M 0.19% 145
2014
Q3 		$15.3M Buy
265,406
+190,825
+256% +$11.7M 0.06% 290
2014
Q2 		$4.99M Buy
+74,581
New +$5.05M 0.02% 457

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Amundi Asset Management US's GSK Position: Q1 2019 in Review

Amundi Asset Management US sold out of GSK (GSK) in Q1 2019, closing a stake of 273,614 shares — an estimated $13.1K sold.

Amundi Asset Management US first reported a position in GSK in Q2 2014 and held it in 19 quarters. The position peaked at $55.8M in Q1 2015. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

  • Amundi Asset Management US reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 273,614 GSK shares in Q1 2019, an estimated $13.1K.
  • Amundi Asset Management US first reported a position in GSK in Q2 2014 and held it in 19 quarters.
  • Amundi Asset Management US's GSK position peaked at $55.8M in Q1 2015.
  • 847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.